Government’s database include health care professionals in many categories, including pharmacists.
Accurate medication reconciliations are critical for ensuring safe patient outcomes, and a correct medication list can help prevent drug-drug interactions, contraindications, and duplicate therapies.
Periodontitis and AD are both characterized by inflammatory and immunological response by the host.
Let’s shine the spotlight on ourselves, and let’s begin to heal.
Pharmacists can step up counseling and advocate for best practices for children with chronic illnesses.
Pharmacist-led post-cardiovascular surgery outpatient glycemic management services help reduce hospital readmissions and sternal wound infections in patients with uncontrolled diabetes who recently underwent an interventional cardiology procedure.
It is important for pharmacists to educate patients, especially those with cardiovascular risks, about the differences between fish oil supplements and prescription n3-FAs products.
Specialty pharmacists—those caring for patients with serious, sometimes life-threatening conditions such as cancer or rheumatologic disease—are not immune from the ongoing labor crisis.
A pharmacist-led transitions of care program reduced chronic obstructive pulmonary disease readmissions by implementing guideline-based inhaler prescribing and addressing medication adherence barriers, decreasing 30-day readmission rates.
New technology and innovation may help turn the corner on antibiotic resistance.
Philip Kuball, MD, neurology resident at NYU Langone Health, highlights the integral role of pharmacists in monitoring patient eligibility, managing dosing schedules, and ensuring safe medication interactions for lecanemab treatment in Alzheimer disease.
Technology is key in supporting and freeing up time for pharmacists to meet vaccination efforts and increased demands in providing community care.
Non–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Small and/or rural hospitals present a great opportunity for self-development and actualization.
Pharmacists can be instrumental in reducing the main challenges in opioid use disorder—namely supply, demand, and harm.
All stakeholders across the drug supply chain must work together to develop and support proactive strategies, creating resilience across the health care ecosystem to avoid and mitigate shortages.
Intravenous immunoglobulin therapy for patients with CIDP requires navigating insurance coverage and prolonged therapy.
Through recognizing the importance of research in the scope of pharmacy practice by national pharmacy organizations, research can become a prominent role and responsibility of pharmacy.
Like most of us who pursue a career in health care, I want to help as many people as I can. I also want to continue to advocate for underrepresented minorities who would like a career in the field.
Drug shortages, infrastructure and wholesaler challenges will be the backdrops of the pharmacy landscape this year.
Panelists discuss how there have been many new agents being studied and released at the current time and how the development of these agents is moving at a rapid pace. The adverse effect profiles of newer antibody-drug conjugates create a greater opportunity for pharmacists to be involved in toxicity management.
Pharmacogenomics is gaining support in mental health and polypharmacy, where the data make a strong case for improvements in clinical and economic outcomes.
We owe it to our seniors to listen to their needs and ensure pharmacists have the support they need to continue to play a vital role in our communities as frontline providers of essential health care.
Cannabis use during pregnancy may harm fetal development and long-term health.
UPMC enhances heart failure patient care through integrated pharmacy and cardiology team collaboration.
Precise, more potent therapy can offer reduced toxicity.